Micromeria graeca (L.) Benth. ex Rchb. (Lamiaceae) is a promising medicinal plant valued for its antioxidant, anti-hyperglycemic, anti-hypertensive, antimicrobial, and anti-aflatoxigenic properties. It is rich in phenolic and flavonoid compounds, supporting its traditional use for digestive, respiratory, cardiovascular, and dermatological conditions. Plant tissue culture facilitates controlled in vitro propagation to study plant growth and bioactive properties. The effects of activated charcoal and varying subculture intervals on multiplication and biomass production in M. graeca shoot cultures were investigated. The phenolic composition of methanolic extracts from in vitro-grown plants was characterized using high-performance liquid chromatography (HPLC), identifying rosmarinic, caffeic, and syringic acids as the primary phenolic compounds. Antimicrobial activity against selected microbial strains was evaluated using a micro-well dilution assay. Anticancer activity of selected extracts was assessed in human hepatocellular carcinoma cell line HepG2, with flow cytometry (Annexin-V/PI staining) used to analyze cell death mechanisms, and compared to pure rosmarinic acid (RA). Activated charcoal showed no beneficial effects on multiplication or biomass production, but significantly increased phenolic acid content (up to 4-fold). RA dominated the phenolic profiles, with other phenolic acids present in lower amounts. Methanolic extracts exhibited negligible antimicrobial activity compared to reference antibiotics and fungicide. Extracts from 4-week-old shoot cultures displayed modest anti-hepatoma activity (IC50 values of CV assay ranging from 193 to 274 µg mL−1), inducing HepG2 cell apoptosis via oxidative stress, independent of RA. Our results suggest that the metabolic output of M. graeca shoot cultures and consequently their biological activity can be modulated by varying in vitro culture conditions. These findings underscore the potential of their methanolic extracts for biotechnological production and therapeutic applications.
Lavandula stoechas (Lamiaceae) is a highly valued medicinal plant due to its rich content of bioactive secondary metabolites, particularly rosmarinic acid. This study aimed to develop an efficient in vitro propagation protocol from seeds and to evaluate the influence of 6-benzylaminopurine (BAP) on morphogenesis and phenolic compound production while comparing the antioxidant and antifungal activities of methanolic extracts from in vitro cultured and wild-growing plants. Seeds were germinated on half-strength MS medium under different sucrose concentrations and temperatures. Nodal explants from seedlings were cultured on full-strength MS medium supplemented with 0, 1, 2, or 3 µM BAP. Methanolic extracts were analyzed for total phenolic content, rosmarinic acid concentration (HPLC), antioxidant activity (DPPH and ABTS assays), and antifungal activity against phytopathogenic fungi. Rapid germination occurred on day 3 on half-strength MS medium with 1% sucrose at 20 °C. The highest biomass production was achieved with 3 µM BAP. In vitro cultured plants accumulated fivefold-higher total phenolic content (217.73 mg GAE g−1 DW) than wild plants (43.23 mg GAE g−1 DW), with significantly higher rosmarinic acid levels. Antioxidant activity was markedly stronger in extracts from plants grown with 1–2 µM BAP, whereas antifungal activity remained limited. These results demonstrate that in vitro propagation with optimized BAP concentrations is an effective strategy for enhancing bioactive metabolite production and supporting the conservation of Tunisian L. stoechas.